Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 11 2024 - 8:30AM
Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ:
DRTS, DRTSW), the developer of the innovative alpha-radiation
cancer therapy Alpha DaRT®, today announced
that CEO Uzi
Sofer and CFO Raphi Levy will present a corporate
overview and update at the J.P. Morgan 43rd Annual
Healthcare Conference on Thursday, January 16, 2025 at 9:45am PT /
12:45pm ET, in San Francisco, CA, and will host institutional
investor meetings at the event.
Event: |
J.P. Morgan 43rd Annual Healthcare Conference |
Format: |
Presentation and 1-on-1 Meetings |
Date: |
January 16, 2025 |
Time: |
9:45AM PT – 10:25AM PT |
Location: |
Westin St. Francis, San Francisco, CA |
Webcast: Link located on the “Events &
Presentations” page in the Investor Relations section on the
Company’s website at https://www.alphatau.com/events
Please reach out to your J.P. Morgan representative to schedule
1-on-1 meetings with Mr. Sofer and Mr. Levy.
About Alpha Tau Medical Ltd.
Founded in 2016, Alpha Tau is an Israeli oncology therapeutics
company that focuses on research, development, and potential
commercialization of the Alpha DaRT for the treatment of solid
tumors. The technology was initially developed by Prof. Itzhak
Kelson and Prof. Yona Keisari from Tel Aviv University.
About Alpha DaRT®
Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is
designed to enable highly potent and conformal alpha-irradiation of
solid tumors by intratumoral delivery of radium-224 impregnated
sources. When the radium decays, its short-lived daughters are
released from the sources and disperse while emitting high-energy
alpha particles with the goal of destroying the tumor. Since the
alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims
to mainly affect the tumor, and to spare the healthy tissue around
it.
Investor Relations Contact: IR@alphatau.com
Alpha Tau Medical (NASDAQ:DRTS)
Historical Stock Chart
From Nov 2024 to Dec 2024
Alpha Tau Medical (NASDAQ:DRTS)
Historical Stock Chart
From Dec 2023 to Dec 2024